Presentation Information
[OS28-1]QUANTI CNS: Efficacy and Safety of Gadoquatrane in Patients Undergoing Contrast-Enhanced MRI of the Central Nervous System at Reduced Gadolinium Dose
○Kohsuke Kudo1, Sophie Hodge2, Alex Liu3, Mark A Klemens4, Birte M Hofmann4, Petra Palkowitsch4 (1.Department of Diagnostic Imaging, Hokkaido University Faculty of Medicine, 2.Clinical Data & Analytics, Bayer Pharma R&D, Reading, Great Britain, 3.Clinical Data & Analytics, Bayer Pharma R&D, Whippany, NJ, USA, 4.Bayer AG, Pharma, Radiology R&D, Berlin, Germany)
Password required to view
Comment
To browse or post comments, you must log in.Log in